Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer-Reference-Cited by-同舟云学术

Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer

Published:2016-10-24 Issue:1 Volume:123 Page:43-51
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Friese Christopher R.¹,Li Yun²,Bondarenko Irina²,Hofer Timothy P.³⁴,Ward Kevin C.⁵,Hamilton Ann S.⁶,Deapen Dennis⁶,Kurian Allison W.⁷⁸,Katz Steven J.³⁹

Affiliation:

1. Department of Systems, Populations, and Leadership, School of Nursing; University of Michigan; Ann Arbor Michigan

2. Department of Biostatistics, School of Public Health; University of Michigan; Ann Arbor Michigan

3. Division of General Medicine, Department of Internal Medicine; University of Michigan; Ann Arbor Michigan

4. Health Services Research and Development Center of Excellence; Ann Arbor Veterans Affairs Medical Center; Ann Arbor Michigan

5. Department of Epidemiology, Rollins School of Public Health; Emory University; Atlanta Georgia

6. Department of Preventive Medicine, Keck School of Medicine; University of Southern California; Los Angeles California

7. Department of Medicine; Stanford University Medical Center; Palo Alto California

8. Department of Health Research and Policy; Stanford University Medical Center; Palo Alto California

9. Department of Health Management and Policy, School of Public Health; University of Michigan; Ann Arbor Michigan

Funder

National Cancer Institute of the National Institutes of Health

California Department of Public Health

National Program of Cancer Registries of the Centers for Disease Control and Prevention

National Cancer Institute

Cancer Prevention Institute of California

University of Southern California

Public Health Institute

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30324/fullpdf

Reference29 articles.

1. Chemotherapy and the recurrence score-results as expected?;Pusztai;Nat Rev Clin Oncol.,2015

2. Biology before anatomy in early breast cancer-precisely the point;Hudis;N Engl J Med.,2015

3. National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology: breast cancer https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#breast

4. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline;Harris;J Clin Oncol.,2016

5. Prospective validation of a 21-gene expression assay in breast cancer;Sparano;N Engl J Med.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer;Journal of Medical Economics;2024-07-25

2. Correlation Between Pre-Chemotherapy AMH Level, Menstrual Status, and Prediction of Ovarian Function Recovery after FAC Chemotherapy AMH in Breast Cancer Patients;Majalah Kedokteran Bandung;2023-09-30

3. Survival analysis of breast cancer patients using machine learning models;Multimedia Tools and Applications;2023-03-21

4. Using multiple imputation to classify potential outcomes subgroups;Statistical Methods in Medical Research;2021-04-22

5. Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland;Breast Cancer Research and Treatment;2021-04-09